Modulation of arachidonic and linoleic acid metabolites in myeloperoxidase-deficient mice during acute inflammation

Free Radical Biology and Medicine

Volumn 48, Issue 10, 2010, Pages 1311-1320

  Kubala, Lukas ^a,b   Schmelzer, Kara R ^c   Klinke, Anna ^d   Kolarova, Hana ^b   Baldus, Stephan ^d   Hammock, Bruce D ^c   Eiserich, Jason P ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

Epoxygenase; Free radicals; Lipoxygenase; Myeloperoxidase; Proinflammatory mediators; Sepsis

Indexed keywords

ARACHIDONIC ACID; ENDOTOXIN; EPOXIDE; FATTY ACID; HYDROXYICOSATETRAENOIC ACID; HYDROXYOCTADECADIENOIC ACID; LINOLEIC ACID; MYELOPEROXIDASE; PEPTIDOLEUKOTRIENE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; INFLAMMATION; KNOCKOUT MOUSE; LIPID BLOOD LEVEL; LIPID OXIDATION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATION; PRIORITY JOURNAL; REGULATORY MECHANISM; WILD TYPE;

ANIMALS; ARACHIDONIC ACID; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; EPOXY COMPOUNDS; FATTY ACIDS, UNSATURATED; HYDROXYEICOSATETRAENOIC ACIDS; INFLAMMATION; LINOLEIC ACID; LIPOPOLYSACCHARIDES; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PEROXIDASE; SHOCK, SEPTIC;

MUS;

EID: 77951894201     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.02.010     Document Type: Article

References (60)

1. Aldridge A.J. Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur. J. Surg. 2002, 168:204-214.
2. Winterbourn C.C., Vissers M.C., Kettle A.J. Myeloperoxidase. Curr. Opin. Hematol. 2000, 7:53-58.
3. Klebanoff S.J. Myeloperoxidase: friend and foe. J. Leukocyte Biol. 2005, 77:598-625.
4. Winterbourn C.C., Hampton M.B., Livesey J.H., Kettle A.J. Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J. Biol. Chem. 2006, 281:39860-39869.
5. Nauseef W.M. Contributions of myeloperoxidase to proinflammatory events: more than an antimicrobial system. Int. J. Hematol. 2001, 74:125-133.
6. Lau D., Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol. Ther. 2006, 111:16-26.
7. Eiserich J.P., Baldus S., Brennan M.L., Ma W., Zhang C., Tousson A., Castro L., Lusis A.J., Nauseef W.M., White C.R., Freeman B.A. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002, 296:2391-2394.
8. Shao B., Oda M.N., Oram J.F., Heinecke J.W. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr. Opin. Cardiol. 2006, 21:322-328.
9. Nicholls S.J., Hazen S.L. Myeloperoxidase and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1102-1111.
10. Heinecke J.W. Tyrosyl radical production by myeloperoxidase: a phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins. Toxicology 2002, 177:11-22.
11. Cook J.A. Eicosanoids. Crit. Care Med. 2005, 33:S488-S491.
12. Kroetz D.L., Zeldin D.C. Cytochrome P450 pathways of arachidonic acid metabolism. Curr. Opin. Lipidol. 2002, 13:273-283.
13. Newman J.W., Morisseau C., Hammock B.D. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog. Lipid Res. 2005, 44:1-51.
14. Schmelzer K.R., Inceoglu B., Kubala L., Kim I.H., Jinks S.L., Eiserich J.P., Hammock B.D. Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors. Proc. Natl. Acad. Sci. USA 2006, 103:13646-13651.
15. Schmelzer K.R., Kubala L., Newman J.W., Kim I.H., Eiserich J.P., Hammock B.D. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc. Natl. Acad. Sci. USA 2005, 102:9772-9777.
16. Yu Z., Xu F., Huse L.M., Morisseau C., Draper A.J., Newman J.W., Parker C., Graham L., Engler M.M., Hammock B.D., Zeldin D.C., Kroetz D.L. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ. Res. 2000, 87:992-998.
17. Moghaddam M.F., Grant D.F., Cheek J.M., Greene J.F., Williamson K.C., Hammock B.D. Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase. Nat. Med. 1997, 3:562-566.
18. Kuhn H., O'Donnell V.B. Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 2006, 45:334-356.
19. Lewis R.A., Lee C.W., Levine L., Morgan R.A., Weiss J.W., Drazen J.M., Oh H., Hoover D., Corey E.J., Austen K.F. Biology of the C-6-sulfidopeptide leukotrienes. Adv. Prostaglandin Thromboxane Leukotriene Res. 1983, 11:15-26.
20. Ortiz de Montellano P.R. Catalytic sites of hemoprotein peroxidases. Annu. Rev. Pharmacol. Toxicol. 1992, 32:89-107.
21. Winterbourn C.C., van den Berg J.J., Roitman E., Kuypers F.A. Chlorohydrin formation from unsaturated fatty acids reacted with hypochlorous acid. Arch. Biochem. Biophys. 1992, 296:547-555.
22. Heinecke J.W., Li W., Mueller D.M., Bohrer A., Turk J. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry 1994, 33:10127-10136.
23. Spickett C.M., Jerlich A., Panasenko O.M., Arnhold J., Pitt A.R., Stelmaszynska T., Schaur R.J. The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids. Acta Biochim. Pol. 2000, 47:889-899.
24. Arnhold J., Osipov A.N., Spalteholz H., Panasenko O.M., Schiller J. Effects of hypochlorous acid on unsaturated phosphatidylcholines. Free Radic. Biol. Med. 2001, 31:1111-1119.
25. Panasenko O.M., Spalteholz H., Schiller J., Arnhold J. Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines. Free Radic. Biol. Med. 2003, 34:553-562.
26. Iwase H., Takahashi T., Takatori T., Shimizu T., Aono K., Yamada Y., Iwadate K., Nagao M. pH dependent alterations of monoepoxides and monochlorohydrins of linoleic acid, and their existence in vivo. Biochem. Biophys. Res. Commun 1995, 215:945-951.
27. Hazen S.L., Hsu F.F., Duffin K., Heinecke J.W. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J. Biol. Chem. 1996, 271:23080-23088.
28. Podrez E.A., Poliakov E., Shen Z., Zhang R., Deng Y., Sun M., Finton P.J., Shan L., Gugiu B., Fox P.L., Hoff H.F., Salomon R.G., Hazen S.L. Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36. J. Biol. Chem. 2002, 277:38503-38516.
29. Schmitt D., Shen Z., Zhang R., Colles S.M., Wu W., Salomon R.G., Chen Y., Chisolm G.M., Hazen S.L. Leukocytes utilize myeloperoxidase-generated nitrating intermediates as physiological catalysts for the generation of biologically active oxidized lipids and sterols in serum. Biochemistry 1999, 38:16904-16915.
30. Zhang R., Shen Z., Nauseef W.M., Hazen S.L. Defects in leukocyte-mediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase-deficient subjects: systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasma. Blood 2002, 99:1802-1810.
31. Savenkova M.L., Mueller D.M., Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 1994, 269:20394-20400.
32. Kapiotis S., Sengoelge G., Hermann M., Held I., Seelos C., Gmeiner B.M. Paracetamol catalyzes myeloperoxidase-initiated lipid oxidation in LDL. Arterioscler. Thromb. Vasc. Biol. 1997, 17:2855-2860.
33. Kapiotis S., Hermann M., Exner M., Laggner H., Gmeiner B.M. Copper- and magnesium protoporphyrin complexes inhibit oxidative modification of LDL induced by hemin, transition metal ions and tyrosyl radicals. Free Radic. Res. 2005, 39:1193-1202.
34. Poliakov E., Brennan M.L., Macpherson J., Zhang R., Sha W., Narine L., Salomon R.G., Hazen S.L. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo. FASEB J. 2003, 17:2209-2220.
35. Zhang R., Brennan M.L., Shen Z., MacPherson J.C., Schmitt D., Molenda C.E., Hazen S.L. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J. Biol. Chem. 2002, 277:46116-46122.
36. Kim I.H., Morisseau C., Watanabe T., Hammock B.D. Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility. J. Med. Chem. 2004, 47:2110-2122.
37. Brennan M., Gaur A., Pahuja A., Lusis A.J., Reynolds W.F. Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2001, 112:97-105.
38. Gaut J.P., Yeh G.C., Tran H.D., Byun J., Henderson J.P., Richter G.M., Brennan M.L., Lusis A.J., Belaaouaj A., Hotchkiss R.S., Heinecke J.W. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc. Natl. Acad. Sci. USA 2001, 98:11961-11966.
39. Brennan M.L., Wu W., Fu X., Shen Z., Song W., Frost H., Vadseth C., Narine L., Lenkiewicz E., Borchers M.T., Lusis A.J., Lee J.J., Lee N.A., Abu-Soud H.M., Ischiropoulos H., Hazen S.L. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J. Biol. Chem. 2002, 277:17415-17427.
40. Luo Y., Dorf M. Isolation of mouse neutrophils. Current Protocols in Immunology 1997, 3.20.21-23.20.26. Wiley InterScience, New York. J. Coligan, B. Bierer, D. Margulies, E. Shevach, W. Strober (Eds.).
41. Hayakawa M., Sugiyama S., Takamura T., Yokoo K., Iwata M., Suzuki K., Taki F., Takahashi S., Ozawa T. Neutrophils biosynthesize leukotoxin, 9,10-epoxy-12-octadecenoate. Biochem. Biophys. Res. Commun. 1986, 137:424-430.
42. Yang J., Schmelzer K., Georgi K., Hammock B.D. Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. Anal. Chem. 2009, 81:8085-8093.
43. Fife K.L., Liu Y., Schmelzer K.R., Tsai H.J., Kim I.H., Morisseau C., Hammock B.D., Kroetz D.L. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation. J. Pharmacol. Exp. Ther. 2008, 327:707-715.
44. Inceoglu B., Jinks S.L., Ulu A., Hegedus C.M., Georgi K., Schmelzer K.R., Wagner K., Jones P.D., Morisseau C., Hammock B.D. Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways. Proc. Natl. Acad. Sci. USA 2008, 105:18901-18906.
45. Werz O., Klemm J., Samuelsson B., Radmark O. Phorbol ester up-regulates capacities for nuclear translocation and phosphorylation of 5-lipoxygenase in Mono Mac 6 cells and human polymorphonuclear leukocytes. Blood 2001, 97:2487-2495.
46. Ozawa T., Sugiyama S., Hayakawa M., Taki F., Hanaki Y. Neutrophil microsomes biosynthesize linoleate epoxide (9,10-epoxy-12-octadecenoate), a biological active substance. Biochem. Biophys. Res. Commun. 1988, 152:1310-1318.
47. Brennan M.L., Anderson M.M., Shih D.M., Qu X.D., Wang X., Mehta A.C., Lim L.L., Shi W., Hazen S.L., Jacob J.S., Crowley J.R., Heinecke J.W., Lusis A.J. Increased atherosclerosis in myeloperoxidase-deficient mice. J. Clin. Invest. 2001, 107:419-430.
48. Podrez E.A., Schmitt D., Hoff H.F., Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J. Clin. Invest. 1999, 103:1547-1560.
49. O'Donnell V.B., Eiserich J.P., Chumley P.H., Jablonsky M.J., Krishna N.R., Kirk M., Barnes S., Darley-Usmar V.M., Freeman B.A. Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem. Res. Toxicol. 1999, 12:83-92.
50. Carr A.C., van den Berg J.J., Winterbourn C.C. Chlorination of cholesterol in cell membranes by hypochlorous acid. Arch. Biochem. Biophys. 1996, 332:63-69.
51. Duescher R.J., Elfarra A.A. 1,3-Butadiene oxidation by human myeloperoxidase: role of chloride ion in catalysis of divergent pathways. J. Biol. Chem. 1992, 267:19859-19865.
52. Mason R.P., Chignell C.F. Free radicals in pharmacology and toxicology-selected topics. Pharmacol. Rev. 1981, 33:189-211.
53. Lee C.W., Lewis R.A., Tauber A.I., Mehrotra M., Corey E.J., Austen K.F. The myeloperoxidase-dependent metabolism of leukotrienes C4, D4, and E4 to 6-trans-leukotriene B4 diastereoisomers and the subclass-specific S-diastereoisomeric sulfoxides. J. Biol. Chem. 1983, 258:15004-15010.
54. Henderson W.R., Klebanoff S.J. Leukotriene production and inactivation by normal, chronic granulomatous disease and myeloperoxidase-deficient neutrophils. J. Biol. Chem. 1983, 258:13522-13527.
55. Neill M.A., Henderson W.R., Klebanoff S.J. Oxidative degradation of leukotriene C4 by human monocytes and monocyte-derived macrophages. J. Exp. Med. 1985, 162:1634-1644.
56. Morgan E.T. Regulation of cytochrome p450 by inflammatory mediators: why and how?. Drug Metab. Dispos. 2001, 29:207-212.
57. Milla C., Yang S., Cornfield D.N., Brennan M.L., Hazen S.L., Panoskaltsis-Mortari A., Blazar B.R., Haddad I.Y. Myeloperoxidase deficiency enhances inflammation after allogeneic marrow transplantation. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 287:L706-L714.
58. Ichimori K., Fukuyama N., Nakazawa H., Aratani Y., Koyama H., Takizawa S., Kameoka Y., Ishida-Okawara A., Kohi F., Suzuki K. Myeloperoxidase has directly-opposed effects on nitration reaction-study on myeloperoxidase-deficient patient and myeloperoxidase-knockout mice. Free Radic. Res. 2003, 37:481-489.
59. Takizawa S., Aratani Y., Fukuyama N., Maeda N., Hirabayashi H., Koyama H., Shinohara Y., Nakazawa H. Deficiency of myeloperoxidase increases infarct volume and nitrotyrosine formation in mouse brain. J. Cereb. Blood Flow Metab. 2002, 22:50-54.
60. Kumar A.P., Ryan C., Cordy V., Reynolds W.F. Inducible nitric oxide synthase expression is inhibited by myeloperoxidase. Nitric Oxide 2005, 13:42-53.